Molecular Testing Turnaround Time for Non-Small Cell Lung Cancer in Routine Clinical Practice Confirms Feasibility of CAP/IASLC/AMP Guideline Recommendations: a single center analysis

This study examines the feasibility of the target molecular testing turnaround time put forward by the CAP/IASLC/AMP guidelines for non-small cell lung cancer. In a retrospective review of all such cases over a one-year period sent out from a large academic institution, 81.5% of testing results were available within the recommended 10 day interval.

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nhpcpK
via IFTTT